Nitrosamines, found in various consumer products and pharmaceuticals, are recognized carcinogens linked to increased cancer risks. Recent discoveries of nitrosamines in commonly prescribed medications, such as valsartan and metformin, have resulted in significant recalls and disrupted patient care. This whitepaper examines the critical issue of nitrosamine contamination in pharmaceuticals and highlights innovative mitigation strategies. Learn how nitrite scavengers, including ascorbic acid and alpha-tocopherol, can serve as functional excipients to block harmful nitrosation reactions, ensuring safer drug formulations and compliance with evolving regulations.
Discover how dsm-firmenich and Bayer reduced vitamin C’s carbon footprint by 49% through renewable energy, process innovation, and sustainable pharma collaboration.
Discover how dsm-firmenich is tackling the challenge of bitter medicine with a receptor-based technology designed to elevate drug palatability and improve patient adherence.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.